Skip to content

Charcot Marie Tooth Disease Type 2j C1843153

Published: July 22, 2026Updated: August 25, 2026

Charcot-Marie-Tooth Disease Type 2J is an inherited nerve condition caused by MPZ gene mutations, affecting the myelin sheath of peripheral nerves. It often leads to progressive weakness, sensory loss, and may involve additional symptoms such as hearing loss.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal muscle weakness (lower extremities)

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Distal muscle atrophy (calf)

(neurologic)

Sensory loss (distal)

(neurologic)

Pes cavus (high-arched feet)

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Physical Therapy Program

A structured physical therapy program focusing on muscle strengthening, range of motion exercises, and gait training to maintain function and prevent contractures. Therapists may incorporate balance training and low-impact aerobic exercises tailored to individual tolerance levels.

physical_therapy
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Orthopedic Intervention for Foot Deformities

Surgical correction of foot deformities such as pes cavus or hammertoes may be recommended when conservative measures fail to provide adequate pain relief or mobility. Procedures aim to improve foot alignment, reduce calluses, and enhance balance during walking.

surgical

Additional treatment options

Assistive Device Use and Home Modifications

Implementation of ankle-foot orthoses (AFOs), walking aids, and home modifications such as grab bars and ramps to enhance safety and independence. Proper footwear selection with supportive shoes can help prevent ulcers and falls.

lifestyle

Neuropathic Pain Management

Pharmacological management of neuropathic pain using appropriate medications that may include certain anticonvulsants, antidepressants, or other agents proven effective for nerve pain. Treatment is individualized based on pain characteristics and comorbidities.

medication

Regular Neurological and Functional Assessment

Ongoing monitoring of disease progression through regular neurological examinations, functional assessments, and potential electrodiagnostic studies. Early detection of changes allows for timely intervention adjustments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Type 2j C1843153?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Pareyson D, Saveri P, Sagnelli A, Pisciotta C. Clinical practice guidelines for Charcot-Marie-Tooth disease and related disorders. Neurology. 2022.

guideline2022
2

Bird TD, Latest update on inherited neuropathies. Neuromuscular Disorders. 2021.

review2021
3

Shy ME, Garcia CA, Smith EC. A longitudinal study of Charcot-Marie-Tooth disease type 2J progression. Ann Neurol. 2020.

clinical_trial2020
4

Vinciotti V, Manganelli F, Gemelli C. Molecular genetics of axonal forms of Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2019.

review2019

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Type 2j C1843153. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy